Login
Create Account
  • Current Issue
  • Archive
  • Departments
  • Subspecialties
  • About
    About AAOS Now Advertising Submissions Editorial Board and Staff Contact the Editor About AAOS Headline News Now AAOS Now Daily Edition
Renew Your Membership by January 1 to Maintain Access to Exclusive Cutting-Edge Resources.

AAOS Now / Issue

AAOS Now, December 2025

Annual Meeting Your AAOS Clinical Quality & Research Practice Management Professional Development Advocacy Residency Biologics Commentary
  • AAOS establishes Orthobiologics Registry to advance evidence-based orthobiologics research

    AAOS announced the development of the AAOS Orthobiologics Registry (OBR), a disease- and condition-focused registry designed to measure the long-term safety, efficacy, and real-world outcomes of orthobiologic therapies for patients diagnosed with knee osteoarthritis.

  • Jason Dragoo, MD, highlights AAOS’ current and future biologics initiatives designed to support orthopaedic care

    Robert M. Orfaly, MD, MBA, FAAOS

    AAOS Now Editor-in-Chief Robert M. Orfaly, MD, MBA, FAAOS, sat down with Jason Dragoo, MD, FAAOS, chair of the AAOS Devices, Biologics, and Technology (DBT) Committee, to discuss what is new in orthobiologics.

  • Ultrasound can play a key role in evaluation, management of musculoskeletal conditions

    Leah Lawrence

    High-frequency, nonaudible sound — ultrasound — has only been harnessed by medicine in recent history.

  • Patients 50 years or younger show favorable midterm outcomes after reverse total shoulder arthroplasty

    Rebecca Araujo

    An ePoster presented at the AAOS 2025 Annual Meeting shows improved pain relief and function after reverse total shoulder arthroplasty (RTSA) in patients aged 50 years or younger.

  • Older patients with pre-existing anemia face significantly worse outcomes after hip fracture surgery

    Heather Knox

    An ePoster presented at the AAOS 2025 Annual Meeting reported the results of a five-year study investigating the effects of pre-injury anemia on morbidity and mortality risk for geriatric patients with hip fractures.

  • Year in review: AAOS Registries release new data tools, risk adjustment, and expanded modules

    Jennifer Lefkowitz

    In 2025, the AAOS Registry Program surpassed 5.5 million procedures collected — a milestone that reflects both growth and innovation.

  • AAOS 2025 Showdowns recap: Surgeons face off in debate on rotator cuff repair options

    Josh Baxt

    On the last day of the AAOS 2025 Annual Meeting, “Showdown: Augmentation of the rotator cuff repair” provided a cheeky (but studiously polite) debate, highlighting different ways to augment cuff repairs, including biologics, grafts, and other techniques.

  • AAOS ICL focuses on baseball pitchers with elbow issues and how to evaluate, repair, and reconstruct UCL tears

    Josh Baxt

    For orthopaedic surgeons, spring brings a wave of baseball pitchers presenting with elbow issues.

  • Study: Arthrodesis and arthroplasty show similar benefits for end-stage ankle arthritis

    Keightley Amen, BA, ELS

    A study presented at the AAOS 2025 Annual Meeting reported that ankle arthrodesis (AA) and total ankle arthroplasty (TAA) are both effective for end-stage ankle arthritis (ESAA) up to 8 years.

  • New evidence compares anesthesia options for hip fracture surgery in older adults

    When treating older adults with hip fractures, choosing between general and spinal anesthesia has long been a topic of clinical discussion.

  • Collaboration between orthopaedic and plastic surgeons on trauma and tumor cases has intriguing benefits

    Leah Lawrence

    Multidisciplinary collaboration between orthopaedic surgeons and plastic surgeons — often called “orthoplastic” surgery — is vital for successful limb salvage in the setting of tumor or trauma.

  • Fresh osteochondral allograft transplantation is a promising option for athletes with osteochondritis dissecans of the capitellum

    Rebecca Araujo

    Researchers from Kaiser Permanente found that fresh osteochondral allograft transplantation (FOCAT) demonstrated favorable mid-term outcomes for the resurfacing of osteochondritis dissecans (OCD) lesions of the humeral capitellum.

Please log in.

Some AAOS Now articles are available only to AAOS members. Please log in to access this article.

 
Not a member? Become a member.

  • 9400 West Higgins Road

    Rosemont, Illinois 60018

    Phone: 847.823.7186

    Fax: 847.823.8125

    • About AAOS
    • Online Learning
    • Clinical Practice Guidelines
    • Career Center
    • Newsroom
    • Find an Orthopaedist
    • Contact Us
    • Corporate Engagement
    • Join the AAOS Team
    • Privacy Policy
    • Terms of Use
    • Code of Conduct

© 1995-2025 by the American Academy of Orthopaedic Surgeons. "All Rights Reserved." This website and its contents may not be reproduced in whole or in part without written permission. "American Academy of Orthopaedic Surgeons" and its associated seal and "American Association of Orthopaedic Surgeons" and its logo are all registered U.S. trademarks and may not be used without written permission.